In addition, many reports indicated that relatively high PD-L1 expression in EGFR-mutated NSCLC was related to lower response to EGFR-TKIs and worse progression-free survival [57,60,61]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.